{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:48:00Z","timestamp":1756385280056},"reference-count":7,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1111\/bjh.13402","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T13:56:24Z","timestamp":1427723784000},"page":"609-610","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tumour lysis syndrome: new territory for a familiar foe?"],"prefix":"10.1111","volume":"169","author":[{"given":"Emily","family":"Graves","sequence":"first","affiliation":[{"name":"Department of Haematology Newcastle\u2010upon\u2010Tyne NHS Foundation Trust Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Culligan","sequence":"additional","affiliation":[{"name":"Department of Haematology Aberdeen Royal Infirmary Aberdeen UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08143.x"},{"key":"e_1_2_2_3_1","first-page":"550","article-title":"Effectiveness of a single fixed dose of rasburicase 3\u00a0mg in the management of tumour lysis syndrome","volume":"75","author":"Coutsouvelis J.","year":"2012","journal-title":"British Journal of Clinical Pharmacology"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12415"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13403"},{"key":"e_1_2_2_6_1","first-page":"61","article-title":"Incidence and pathogenesis of tumor lysis syndrome","volume":"147","author":"Locatelli F.","year":"2005","journal-title":"Contributions to Nephrology"},{"key":"e_1_2_2_7_1","first-page":"872","article-title":"Bcl\u20102 inhibitor ABT\u2010199 (GDC\u20100199) monotherapy shows anti\u2010tumor activity including complete remissions in high\u2010risk relapsed\/refractory (R\/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL)","volume":"122","author":"Seymour J.F.","year":"2013","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.212"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.13402","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.13402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:15:37Z","timestamp":1696349737000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.13402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,30]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/bjh.13402"],"URL":"https:\/\/doi.org\/10.1111\/bjh.13402","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,30]]},"assertion":[{"value":"2015-03-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}